Skip to main content
. 2019 Dec 27;71(12):3110–3117. doi: 10.1093/cid/ciz1213

Figure 2.

Figure 2.

Virologic response over time since darunavir/cobicistat/emtricitabine/tenofovir alafenamide rapid initiation (human immunodeficiency virus type 1 RNA <200 copies/mL; observed analysis).